NFE2L2 and metabolic dysfunction-associated steatotic liver disease: Enhancing NRF2 expression can prevent MASLD by reducing lipid accumulation and modulating antioxidant responses, highlighting the involvement of ferroptosis in MASLD and the potential of targeting oxidative stress and iron metabolism in treatment strategies.